We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Neither lender nor borrower be

30 March 2016 By Robert Cyran

The drugmaker wants to extend its deadline for filing financial statements and ease interest-coverage covenants. The latter request would insure against a cash-flow crisis but it’s still alarming. Creditors will demand a pound of flesh and control of Valeant’s destiny in return.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)